Fabrice André

Fabrice André is a Professor at Université Paris-Saclay and a medical oncologist who leads a team of 100 researchers at the Molecular Predictors and New Targets in Oncology mixed research unit (PMNCO - Université Paris-Saclay, Institut Gustave Roussy, Inserm). His work focuses on large-scale molecular analyses to identify cancer anomalies and develop personalized treatment strategies through virtual tumor modeling and high-throughput technologies like genome and single-cell analysis.

His research spans basic to applied oncology, leveraging Université Paris-Saclay’s interdisciplinary expertise in mathematics, bioinformatics, and physics. He aims to create molecular tests that predict treatment efficacy and reduce cancer mortality. Notably, he co-authored two landmark studies in 2019 in Nature and the New England Journal of Medicine.

Scientific Awards:

• Young Investigator and Career Development award (ASCO)